Ha, K., Fiskus, W., Choi, D. S., Bhaskara, S., Cerchietti, L., Devaraj, S. G. T., . . . Bhalla, K. N. (2014). Histone deacetylase inhibitor treatment induces ‘BRCAness’ and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells. Impact Journals LLC.
Citação norma ChicagoHa, Kyungsoo, et al. Histone Deacetylase Inhibitor Treatment Induces ‘BRCAness’ and Synergistic Lethality With PARP Inhibitor and Cisplatin against Human Triple Negative Breast Cancer Cells. Impact Journals LLC, 2014.
Citação norma MLAHa, Kyungsoo, et al. Histone Deacetylase Inhibitor Treatment Induces ‘BRCAness’ and Synergistic Lethality With PARP Inhibitor and Cisplatin against Human Triple Negative Breast Cancer Cells. Impact Journals LLC, 2014.